Physicians’ Education Resource® Plans Most Impactful Miami Breast Cancer Conference® ever

Share Article

Top breast cancer oncologists to collaborate in order to improve treatment options and patient care

News Image
"I would go so far as to say there will never be another text book, old fashioned text book printed on paper, about breast cancer in our lifetime because the rate of change is too great." - Dr. Patrick Borgen

Physicians' Education Resource® (PER®) will host the 34th Annual Miami Breast Conference, which has been bringing together top surgical, medical, and radiation oncologists, with the aim of fostering awareness of the state-of-the-art treatments in each therapeutic area and encouraging cross team cooperation in the clinic. The conference, will be chaired by Patrick I. Borgen, MD, chair, Department of Surgery Maimonides Medical Center Brooklyn, New York.

“We are in a renaissance period in the understanding of breast cancer. The rate of change, of what we do clinically, of how we put this disease into boxes, of how we predict response, has never, ever changed at a faster rate,” Dr. Borgen says. “I would go so far as to say there will never be another text book, old fashioned text book printed on paper, about breast cancer in our lifetime because the rate of change is too great. By the time you got the book at Barnes and Noble and got it home, it would be out of date…So this really makes Miami important.”

Miami Breast Cancer Conference will present 90 lectures in a highly interactive survey forum, which allows the top oncologists to collaborate to improve clinical pathways and clinical algorithms. The conference will also include Medical Crossfire® debates where oncologists can voice their opinions on some the field’s most pressing issues. This year’s debates include whether field radiation therapy is ready for the main stage, and whether extended hormone blockade needed for every patient diagnosed with ER positive breast cancer.”

Dr. Borgen added, “Everything about Miami is geared towards our mantra of ‘hear it Friday and use it on Monday.’ So, this is a clinical-based conference — this is like our tumor boards back home. Virtually every one of our 90 lectures has a clinical case thumbnail with a question.”

The conference also includes a massive poster session, which contains 70 posters signifying some of the top breast cancer research from 15 countries, so that research can take a more global approach to breast cancer care.

About PER®
Since 1995, PER® has been the educational resource of choice for live and online activities focusing on oncology and hematology. PER® provides high-quality, evidence-based activities featuring leading national and international faculty with a focus on practice-changing advances and standards of care in treatment and disease management. Activities also include topics on emerging strategies currently under investigation, supportive care, diagnosis and staging, prevention, screening and early detection, and practice management. With the rapid advances occurring in the field of oncology, understanding how to use molecular data to diagnose and stage patients, selecting the most appropriate candidates for novel therapeutic agents, individualizing treatment based on tumor type, and referring patients to clinical trials will continue to ensure the highest level of patient care is provided. PER® serves the oncology health care community, including physicians, fellows, advanced practice nurses, nurses, physician assistants, pharmacists, and researchers. PER® is part of the Cranbury, N.J.-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Theresa Burek
PER
+1 609-649-0806
Email >